Farmacosmo Future Growth
Future criteria checks 1/6
Farmacosmo is forecast to grow earnings and revenue by 82.8% and 8.5% per annum respectively while EPS is expected to grow by 56.6% per annum.
Key information
82.8%
Earnings growth rate
56.6%
EPS growth rate
| Specialty Retail earnings growth | 38.2% |
| Revenue growth rate | 8.5% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 28 Oct 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 83 | 0 | 2 | 4 | 2 |
| 12/31/2025 | 76 | -1 | 1 | 2 | 2 |
| 12/31/2024 | 69 | -3 | -1 | 0 | 2 |
| 6/30/2024 | 68 | -4 | 0 | -1 | N/A |
| 3/31/2024 | 70 | -4 | -3 | -3 | N/A |
| 12/31/2023 | 72 | -3 | -7 | -5 | N/A |
| 9/30/2023 | 72 | -2 | N/A | N/A | N/A |
| 6/30/2023 | 72 | -1 | N/A | N/A | N/A |
| 3/31/2023 | 69 | -1 | N/A | N/A | N/A |
| 12/31/2022 | 67 | -1 | N/A | N/A | N/A |
| 9/30/2022 | 66 | -1 | N/A | N/A | N/A |
| 6/30/2022 | 64 | 0 | N/A | N/A | N/A |
| 3/31/2022 | 61 | 0 | N/A | N/A | N/A |
| 12/31/2021 | 58 | 0 | -1 | 0 | N/A |
| 9/30/2021 | 56 | 1 | N/A | N/A | N/A |
| 12/31/2020 | 44 | 0 | 1 | 2 | N/A |
| 12/31/2019 | 24 | 0 | -1 | -1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ZJ1 is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: ZJ1 is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: ZJ1 is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: ZJ1's revenue (8.5% per year) is forecast to grow faster than the German market (5.6% per year).
High Growth Revenue: ZJ1's revenue (8.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if ZJ1's Return on Equity is forecast to be high in 3 years time